Endurance Wealth Management, Inc. Editas Medicine, Inc. Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 400 shares of EDIT stock, worth $552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$552
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
228Shares Held
54.7MCall Options Held
425KPut Options Held
306K-
Black Rock Inc. New York, NY7.78MShares$10.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$9.42 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.79 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$2.98 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.58 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $94.9M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...